Ligand validation:6MLB

RET: RETINAL

RET is a Ligand Of Interest in 6MLB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MLB_RET_D_206	16%	65%	0.301	0.875	0.73	0.61	1	-	1	0	100%	1
6MLB_RET_C_204	9%	64%	0.393	0.88	0.72	0.67	1	-	2	0	100%	1
4QYP_RET_B_201	60%	33%	0.117	0.901	1.07	1.56	1	5	12	0	100%	1
5U6G_RET_L_201	45%	28%	0.198	0.941	0.63	2.19	-	8	2	0	95%	1
4RUU_RET_A_201	33%	29%	0.176	0.853	0.68	2.1	-	6	3	0	100%	1
4EXZ_RET_B_202	27%	30%	0.117	0.899	0.6	2.13	-	2	0	0	24%	1
4ZJ0_RET_A_202	27%	37%	0.133	0.905	1.03	1.43	-	1	0	0	29%	1
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	8	0	100%	1
9F9J_RET_A_317	100%	71%	0.026	0.991	0.7	0.44	1	-	5	0	100%	1
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	1
7XJC_RET_A_301	100%	10%	0.028	0.992	1.93	2.43	2	14	2	0	100%	0.5
7XJD_RET_A_301	100%	10%	0.029	0.991	1.93	2.42	2	14	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.